Header Logo

Connection

ELIZABETH SHPALL to Bone Marrow

Back to Details
This is a "connection" page, showing publications ELIZABETH SHPALL has written about Bone Marrow.
ELIZABETH SHPALL
Connection Strength
0.677
Bone Marrow
  1. Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia. Acta Haematol. 2021; 144(1):74-81.
    View in: PubMed
    Score: 0.102
  2. Release of tumor cells from bone marrow. Blood. 1994 Feb 01; 83(3):623-5.
    View in: PubMed
    Score: 0.066
  3. Lenalidomide-induced graft-vs.-Leukemia effect in a patient with chronic lymphocytic leukemia who relapsed after allogeneic stem cell transplant. Clin Lymphoma Myeloma Leuk. 2014 Jun; 14(3):e105-9.
    View in: PubMed
    Score: 0.065
  4. Regulation of HIF-1a signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment. Cancer Biol Ther. 2012 Aug; 13(10):858-70.
    View in: PubMed
    Score: 0.059
  5. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation. Bone Marrow Transplant. 1991 Feb; 7(2):145-51.
    View in: PubMed
    Score: 0.053
  6. 4-Hydroperoxycyclophosphamide purging of breast cancer from the mononuclear cell fraction of bone marrow in patients receiving high-dose chemotherapy and autologous marrow support: a phase I trial. J Clin Oncol. 1991 Jan; 9(1):85-93.
    View in: PubMed
    Score: 0.053
  7. Impairment of filgrastim-induced stem cell mobilization after prior lenalidomide in patients with multiple myeloma. Biol Blood Marrow Transplant. 2009 Jun; 15(6):718-23.
    View in: PubMed
    Score: 0.047
  8. Bone Marrow versus Peripheral Blood Grafts for Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide. Transplant Cell Ther. 2021 12; 27(12):1003.e1-1003.e13.
    View in: PubMed
    Score: 0.028
  9. Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma. J Neurosurg. 2022 Mar 01; 136(3):757-767.
    View in: PubMed
    Score: 0.028
  10. Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support. Breast Cancer Res Treat. 1996; 41(1):1-13.
    View in: PubMed
    Score: 0.019
  11. Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination alone. Hum Pathol. 1994 Aug; 25(8):781-8.
    View in: PubMed
    Score: 0.017
  12. CD4(-)/CD8(-) variant of T-cell large granular lymphocytic leukemia or hepatosplenic T-cell lymphoma: a clinicopathologic dilemma. Clin Lymphoma Myeloma Leuk. 2013 Oct; 13(5):610-3.
    View in: PubMed
    Score: 0.016
  13. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment. Blood. 2013 Jul 18; 122(3):357-66.
    View in: PubMed
    Score: 0.016
  14. The effect of PIXY-321 on 4-hydroperoxycyclophosphamide purged and CD34+ positively selected bone marrow. Prog Clin Biol Res. 1992; 377:321-5.
    View in: PubMed
    Score: 0.014
  15. Detection of minimal residual breast cancer in bone marrow. Prog Clin Biol Res. 1992; 377:637-42.
    View in: PubMed
    Score: 0.014
  16. Elimination of clonogenic breast cancer cells from human bone marrow. A comparison of immunotoxin treatment with chemoimmunoseparation using 4-hydroperoxycyclophosphamide, monoclonal antibodies, and magnetic microspheres. Cancer. 1991 Sep 15; 68(6):1272-8.
    View in: PubMed
    Score: 0.014
  17. Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104. PLoS One. 2011; 6(8):e23108.
    View in: PubMed
    Score: 0.014
  18. Detection of breast carcinoma cells in human bone marrow using fluorescence-activated cell sorting and conventional cytology. Am J Clin Pathol. 1990 Jul; 94(1):8-13.
    View in: PubMed
    Score: 0.013
  19. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation. Prog Clin Biol Res. 1990; 333:321-35; discussion 336.
    View in: PubMed
    Score: 0.012
  20. Elimination of malignant clonogenic breast cancer cells from human bone marrow. Cancer Res. 1989 Aug 15; 49(16):4659-64.
    View in: PubMed
    Score: 0.012
  21. Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn Ther. 1998 Jan-Feb; 13(1):8-14.
    View in: PubMed
    Score: 0.005
  22. Multilineage engraftment in NOD/LtSz-scid/scid mice from mobilized human CD34+ peripheral blood progenitor cells. Biol Blood Marrow Transplant. 1997 Nov; 3(5):236-46.
    View in: PubMed
    Score: 0.005
  23. The use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous bone marrow transplantation. Prog Clin Biol Res. 1990; 338:121-8.
    View in: PubMed
    Score: 0.003
  24. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation. N Engl J Med. 1988 Apr 07; 318(14):869-76.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.